Brind.

The FDA and EMA are jointly pushing for the adoption and use of alternative testing assays.

3 reports, 3 independent Updated Jun 29

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

The FDA and EMA are jointly pushing for the adoption and use of alternative testing assays.

Who's involved

What this event is mainly about

FDA EMA

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
EMA
Japanese vocalist of the group DUSTCELL

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jun 29forbes.com
Sep 2Clinical Trials ArenaPodcast: Alternative testing models to shape toxicology “with time” In this episode of the GlobalData Healthcare podcast, Annabel Kartal-Allen chats with Charles River Laboratories' Head of GLBL Toxi
Aug 8GlobeNewswireAnnexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy New Pilot Appoints Designated